Home › Companies › EDITAS MEDICINE INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and EDITAS MEDICINE INC.’s Form 8-K, filed June 2, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 29, 2025: 7 items on EDITAS MEDICINE INC.’s Form 8-K, filed June 2, 2025: 4 approved · 2 passed (calculated) · 1 without a stated outcome.
Significant dissent: 1 director (20.0% against).
Notable dissent: 1 equity or compensation plan (23.8% against); 2 other board items (38.9%, 25.4% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025 2025-2026
Activist investors: Ra Capital Management, L.P. (13F, 5.8%, as of September 30, 2026)
Explore EDITAS MEDICINE INC. in the interactive database Compare manager voting policies
These tallies are EDITAS MEDICINE INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 2, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Jessica Hopfield, Ph.D. | 21,212,129 | -- | -- | 5,317,351 | 26,052,859 | 80% | Passed (calculated) | — |
| Elect Director: David Scadden, M.D. | 24,052,406 | -- | -- | 2,477,074 | 26,052,859 | 91% | Passed (calculated) | — |
| 2. The compensation paid to its named executive officers | 16,066,738 | 10,241,052 | 221,690 | -- | 26,052,859 | 61% | Approved | — |
| 3. A frequency of one year for future advisory votes on the compensation paid to its named executive officers | 25,160,123 | -- | 316,138 | -- | 26,052,859 | — | Not verified | — |
| 4. An amendment and restatement of the Company's 2015 Stock Incentive Plan | 20,101,589 | 6,265,763 | 162,128 | -- | 26,052,859 | 76% | Approved | — |
| 5. And approved an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of the Company's capital stock from 200,000,000 to 395,000,000 and the number of authorized shares of the Company's common stock fro | 38,719,409 | 13,205,693 | 657,237 | -- | 0 | 75% | Approved | — |
| 6. The selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the current fiscal year | 51,108,970 | 1,162,233 | 311,136 | -- | 0 | 98% | Approved | — |
Source: EDITAS MEDICINE INC., Form 8-K, filed with the SEC on June 2, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
232 asset managers disclosed a vote on at least one EDITAS MEDICINE INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of EDITAS MEDICINE INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 4 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Description as filed by funds: Election of two Class III Directors, each to serve until the 2028 annual meeting of stockholders: David T. Scadden, M.D.
EDITAS MEDICINE INC.’s own tally for this item (“Elect Director: David Scadden, M.D.”): 24,052,406 for, 2,477,074 withheld, per its Form 8-K filed June 2, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 12,579,309 for, 423,528 withheld, 91,911 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,934,797 | 0 | 0 | 0 | For |
| BlackRock | 2,107,181 | 0 | 0 | 0 | For |
| Fidelity | 1,723,470 | 0 | 0 | 0 | For |
| Charles Schwab | 684,883 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 245,741 | Withhold |
| Goldman Sachs | 191,451 | 0 | 0 | 0 | For |
| SEI | 175,038 | 0 | 0 | 0 | For |
| Equitable | 14,369 | 0 | 0 | 133,630 | Mixed |
| Global X | 147,410 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 114,842 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 0 | 0 | 75,674 | 0 | Abstain |
| Lincoln Financial | 61,938 | 0 | 0 | 3,993 | Mixed |
| Thrivent | 59,541 | 0 | 0 | 0 | For |
| Pacific Life | 48,074 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 39,850 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 39,798 | Withhold |
| Invesco | 36,296 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 34,530 | 0 | 0 | 0 | For |
| Listed Funds Trust | 31,670 | 0 | 0 | 0 | For |
| Voya | 24,546 | 0 | 0 | 0 | For |
| ProShares | 22,932 | 0 | 0 | 0 | For |
| John Hancock | 15,423 | 0 | 4,847 | 0 | Mixed |
| BRIDGEWAY FUNDS INC | 20,000 | 0 | 0 | 0 | For |
| Allspring | 18,979 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 18,600 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
Description as filed by funds: Election of two Class III Directors, each to serve until the 2028 annual meeting of stockholders: Jessica Hopfield, Ph.D.
EDITAS MEDICINE INC.’s own tally for this item (“Elect Director: Jessica Hopfield, Ph.D.”): 21,212,129 for, 5,317,351 withheld, per its Form 8-K filed June 2, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 80% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 12,124,544 for, 862,870 withheld, 107,334 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,934,797 | 0 | 0 | 0 | For |
| BlackRock | 2,107,181 | 0 | 0 | 0 | For |
| Fidelity | 1,705,970 | 0 | 0 | 17,500 | For |
| Charles Schwab | 684,883 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 245,741 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 191,451 | Withhold |
| SEI | 175,038 | 0 | 0 | 0 | For |
| Equitable | 14,369 | 0 | 0 | 133,630 | Mixed |
| Global X | 147,410 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 114,842 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 0 | 0 | 75,674 | 0 | Abstain |
| Lincoln Financial | 61,938 | 0 | 0 | 3,993 | Mixed |
| Thrivent | 0 | 0 | 0 | 59,541 | Withhold |
| Pacific Life | 48,074 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 39,850 | 0 | 0 | 0 | For |
| Northern Trust | 39,798 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 0 | 36,296 | Withhold |
| MASTER INVESTMENT PORTFOLIO | 34,530 | 0 | 0 | 0 | For |
| Listed Funds Trust | 0 | 0 | 0 | 31,670 | Withhold |
| Voya | 0 | 0 | 0 | 24,546 | Withhold |
| ProShares | 0 | 0 | 0 | 22,932 | Withhold |
| John Hancock | 0 | 0 | 20,270 | 0 | Abstain |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 20,000 | Withhold |
| Allspring | 0 | 0 | 0 | 18,979 | Withhold |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 18,600 | Withhold |
Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
75% Approved · of votes cast
Description as filed by funds: TO ADOPT AND APPROVE AN AMENDMENT TO THE COMPANY'S RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF THE COMPANY'S CAPITAL STOCK FROM 200,000,000 TO 395,000,000 AND THE NUMBER OF AUTHORIZED SHARES OF THE COMPANY'S COMMON STOCK FROM 195,000,000 TO 390,000,000.
EDITAS MEDICINE INC.’s own tally for this item (“5. And approved an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of the Company's capital stock from 200,000,000 to 395,000,000 and the number of authorized ”): 38,719,409 for, 13,205,693 against — passed, per its Form 8-K filed June 2, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders adopted and approved an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of the Company's capital stock from 200,000,000 to 395,000,000 and the number of authorized shares of the Company's common stock from 195,0…”
Support: 75% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 48 asset managers below reported 10,369,088 for, 2,798,286 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,934,797 | 0 | 0 | 0 | For |
| BlackRock | 2,107,181 | 0 | 0 | 0 | For |
| Fidelity | 17,500 | 1,705,970 | 0 | 0 | Against |
| Charles Schwab | 0 | 684,883 | 0 | 0 | Against |
| Dimensional | 245,741 | 0 | 0 | 0 | For |
| Goldman Sachs | 191,451 | 0 | 0 | 0 | For |
| SEI | 0 | 175,038 | 0 | 0 | Against |
| Equitable | 147,999 | 0 | 0 | 0 | For |
| Global X | 0 | 147,410 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 114,842 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 0 | 75,674 | 0 | 0 | Against |
| Investment Managers Series Trust II | 71,526 | 0 | 0 | 0 | For |
| Lincoln Financial | 65,931 | 0 | 0 | 0 | For |
| Thrivent | 59,541 | 0 | 0 | 0 | For |
| Pacific Life | 48,074 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 39,850 | 0 | 0 | 0 | For |
| Northern Trust | 39,798 | 0 | 0 | 0 | For |
| Invesco | 36,296 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 34,530 | 0 | 0 | 0 | For |
| Listed Funds Trust | 31,670 | 0 | 0 | 0 | For |
| Voya | 24,546 | 0 | 0 | 0 | For |
| ProShares | 22,932 | 0 | 0 | 0 | For |
| John Hancock | 20,270 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 20,000 | 0 | 0 | 0 | For |
| Allspring | 18,979 | 0 | 0 | 0 | For |
Showing the 25 largest of 48 asset managers. All 48 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
76% Approved · of votes cast
Description as filed by funds: TO APPROVE AN AMENDMENT AND RESTATEMENT OF THE COMPANY'S 2015 STOCK INCENTIVE PLAN.
EDITAS MEDICINE INC.’s own tally for this item (“4. An amendment and restatement of the Company's 2015 Stock Incentive Plan”): 20,101,589 for, 6,265,763 against — passed, per its Form 8-K filed June 2, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved an amendment and restatement of the Company's 2015 Stock Incentive Plan.”
Support: 76% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 12,384,571 for, 782,945 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,934,797 | 0 | 0 | 0 | For |
| BlackRock | 2,107,181 | 0 | 0 | 0 | For |
| Fidelity | 1,705,970 | 17,500 | 0 | 0 | For |
| Charles Schwab | 684,883 | 0 | 0 | 0 | For |
| Dimensional | 0 | 245,741 | 0 | 0 | Against |
| Goldman Sachs | 191,451 | 0 | 0 | 0 | For |
| SEI | 175,038 | 0 | 0 | 0 | For |
| Equitable | 14,369 | 133,630 | 0 | 0 | Mixed |
| Global X | 147,410 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 114,842 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 0 | 75,674 | 0 | 0 | Against |
| Investment Managers Series Trust II | 71,526 | 0 | 0 | 0 | For |
| Lincoln Financial | 61,938 | 3,993 | 0 | 0 | Mixed |
| Thrivent | 0 | 59,541 | 0 | 0 | Against |
| Pacific Life | 48,074 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 39,850 | 0 | 0 | 0 | For |
| Northern Trust | 39,798 | 0 | 0 | 0 | For |
| Invesco | 0 | 36,296 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 34,530 | 0 | 0 | 0 | For |
| Listed Funds Trust | 0 | 31,670 | 0 | 0 | Against |
| Voya | 0 | 24,546 | 0 | 0 | Against |
| ProShares | 0 | 22,932 | 0 | 0 | Against |
| John Hancock | 0 | 20,270 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 20,000 | 0 | 0 | Against |
| Allspring | 0 | 18,979 | 0 | 0 | Against |
Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
90% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: To approve, on an advisory basis, the frequency of future advisory votes on the compensation paid to the Company's named executive officers.
Also reported under other wordings, matched to the same row of EDITAS MEDICINE INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote on Say on Pay Frequency” (2 managers, 735,020 1 year).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| SEI | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| Global X | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| Amplify ETF Trust | 0 | 0 | 0 | 0 | -- |
| Investment Managers Series Trust II | 71,526 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| Thrivent | 0 | 0 | 0 | 0 | -- |
| Pacific Life | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 0 | -- |
| Listed Funds Trust | 0 | 0 | 0 | 0 | -- |
| Voya | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 0 | -- |
| Allspring | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 45 managers: 71,526 for, 12,829,237 1 year, 265,491 3 year. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | Not Voted |
| STIFEL NICOLAUS & CO INC \MO\ | 0 | 0 | 0 | 0 | -- |
| UBS | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| KENNEDY CAPITAL MANAGEMENT LLC | 0 | 0 | 0 | 0 | -- |
| DE Shaw | 0 | 0 | 0 | 0 | -- |
| Renaissance | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Green Alpha Advisors, LLC | 203,658 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| MARSHALL WACE, LLP | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| AQR | 0 | 0 | 0 | 0 | -- |
| AllianceBernstein | 0 | 0 | 0 | 0 | -- |
| Nuveen | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| Prudential/PGIM | 0 | 0 | 0 | 0 | -- |
| Texas Yale Capital Corp. | 0 | 0 | 0 | 0 | -- |
| Thrivent | 0 | 0 | 0 | 0 | -- |
| Two Sigma | 0 | 0 | 0 | 0 | -- |
| Rhumbline | 0 | 27,416 | 0 | 0 | Against |
Institutional-manager reports, all 197 managers: 208,617 for, 29,593 against, 770 abstained, 13,731 not voted, 9,199,974 1 year, 172,619 3 year, 80 2 year, 50 unknown. Showing the 25 largest; every one is in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
59% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,934,797 | 0 | 0 | 0 | For |
| BlackRock | 0 | 2,107,181 | 0 | 0 | Against |
| Fidelity | 1,705,970 | 17,500 | 0 | 0 | For |
| Charles Schwab | 0 | 684,883 | 0 | 0 | Against |
| Dimensional | 0 | 245,741 | 0 | 0 | Against |
| Goldman Sachs | 191,451 | 0 | 0 | 0 | For |
| SEI | 175,038 | 0 | 0 | 0 | For |
| Equitable | 0 | 147,999 | 0 | 0 | Against |
| Global X | 147,410 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 114,842 | 0 | 0 | Against |
| Amplify ETF Trust | 0 | 75,674 | 0 | 0 | Against |
| Investment Managers Series Trust II | 0 | 71,526 | 0 | 0 | Against |
| Lincoln Financial | 61,938 | 3,993 | 0 | 0 | Mixed |
| Thrivent | 0 | 59,541 | 0 | 0 | Against |
| Pacific Life | 0 | 48,074 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 39,850 | 0 | 0 | Against |
| Northern Trust | 39,798 | 0 | 0 | 0 | For |
| Invesco | 0 | 36,296 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 34,530 | 0 | 0 | 0 | For |
| Listed Funds Trust | 0 | 31,670 | 0 | 0 | Against |
| Voya | 0 | 24,546 | 0 | 0 | Against |
| ProShares | 0 | 22,932 | 0 | 0 | Against |
| John Hancock | 0 | 20,270 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 20,000 | 0 | 0 | Against |
| Allspring | 0 | 18,979 | 0 | 0 | Against |
Fund voting reports, all 45 managers: 9,308,593 for, 3,857,661 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 48,577 | 1,891,045 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 1,856,777 | 0 | 0 | 0 | For |
| State Street | 896,309 | 5,261 | 0 | 0 | For |
| Charles Schwab | 0 | 684,896 | 0 | 0 | Against |
| STIFEL NICOLAUS & CO INC \MO\ | 0 | 364,720 | 0 | 0 | Against |
| UBS | 0 | 360,502 | 0 | 0 | Against |
| Northern Trust | 324,769 | 0 | 0 | 0 | For |
| KENNEDY CAPITAL MANAGEMENT LLC | 0 | 307,144 | 0 | 0 | Against |
| DE Shaw | 0 | 227,317 | 0 | 0 | Against |
| Renaissance | 0 | 205,937 | 0 | 0 | Against |
| Vanguard | 182,062 | 23,492 | 0 | 0 | Mixed |
| SEI | 175,508 | 0 | 0 | 0 | For |
| Dimensional | 0 | 172,529 | 0 | 0 | Against |
| MARSHALL WACE, LLP | 144,306 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 143,342 | 0 | 0 | 0 | For |
| AQR | 0 | 137,119 | 0 | 0 | Against |
| AllianceBernstein | 0 | 133,630 | 0 | 0 | Against |
| Nuveen | 0 | 85,595 | 0 | 0 | Against |
| Invesco | 0 | 81,608 | 0 | 0 | Against |
| Prudential/PGIM | 0 | 70,507 | 0 | 0 | Against |
| Texas Yale Capital Corp. | 70,000 | 0 | 0 | 0 | For |
| Thrivent | 0 | 61,111 | 0 | 0 | Against |
| Two Sigma | 0 | 56,011 | 0 | 0 | Against |
| Rhumbline | 0 | 27,416 | 0 | 0 | Against |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0 | 43,375 | 0 | 0 | Against |
Institutional-manager reports, all 197 managers: 4,059,650 for, 5,321,366 against, 770 abstained, 13,731 not voted, 27,416 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
98% Approved · of votes cast
Prior year: 99.4% for (May 30, 2024 meeting) ▼ 1.6 pts
Description as filed by funds: TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.
EDITAS MEDICINE INC.’s own tally for this item (“6. The selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the current fiscal year”): 51,108,970 for, 1,162,233 against — passed, per its Form 8-K filed June 2, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the current fiscal year.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 47 asset managers below reported 13,090,754 for, 76,520 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,934,797 | 0 | 0 | 0 | For |
| BlackRock | 2,107,181 | 0 | 0 | 0 | For |
| Fidelity | 1,723,470 | 0 | 0 | 0 | For |
| Charles Schwab | 684,883 | 0 | 0 | 0 | For |
| Dimensional | 245,741 | 0 | 0 | 0 | For |
| Goldman Sachs | 191,451 | 0 | 0 | 0 | For |
| SEI | 175,038 | 0 | 0 | 0 | For |
| Equitable | 147,999 | 0 | 0 | 0 | For |
| Global X | 147,410 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 114,842 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 0 | 75,674 | 0 | 0 | Against |
| Investment Managers Series Trust II | 71,526 | 0 | 0 | 0 | For |
| Lincoln Financial | 65,931 | 0 | 0 | 0 | For |
| Thrivent | 59,541 | 0 | 0 | 0 | For |
| Pacific Life | 48,074 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 39,850 | 0 | 0 | 0 | For |
| Northern Trust | 39,798 | 0 | 0 | 0 | For |
| Invesco | 36,296 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 34,530 | 0 | 0 | 0 | For |
| Listed Funds Trust | 31,670 | 0 | 0 | 0 | For |
| Voya | 24,546 | 0 | 0 | 0 | For |
| ProShares | 22,932 | 0 | 0 | 0 | For |
| John Hancock | 20,270 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 20,000 | 0 | 0 | 0 | For |
| Allspring | 18,979 | 0 | 0 | 0 | For |
Showing the 25 largest of 47 asset managers. All 47 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 83,709,536 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 8.28% |
| 2 | BlackRock | 2.52% |
| 3 | Fidelity | 2.06% |
| 4 | Charles Schwab | 0.82% |
| 5 | Dimensional | 0.29% |
| 6 | Goldman Sachs | 0.23% |
| 7 | SEI | 0.21% |
| 8 | Equitable | 0.18% |
| 9 | Global X | 0.18% |
| 10 | QUANTITATIVE MASTER SERIES LLC | 0.14% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 2.32% |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 2.22% |
| 3 | State Street | 1.08% |
| 4 | Charles Schwab | 0.83% |
| 5 | STIFEL NICOLAUS & CO INC \MO\ | 0.44% |
| 6 | UBS | 0.43% |
| 7 | Northern Trust | 0.39% |
| 8 | KENNEDY CAPITAL MANAGEMENT LLC | 0.37% |
| 9 | DE Shaw | 0.27% |
| 10 | Renaissance | 0.25% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Commodore Capital LP | 16,045,802 | 19.17% | Schedule 13G, filed June 2, 2026 |
| TCG Crossover GP III, LLC | 15,798,999 | 18.87% | Schedule 13G, filed June 3, 2026 |
| Vanguard Group | 7,466,254 | 8.92% | Form 13F, quarter ended March 31, 2025 |
| BlackRock | 6,690,680 | 7.99% | Form 13F, quarter ended March 31, 2025 |
| Morgan Stanley | 2,658,921 | 3.18% | Form 13F, quarter ended March 31, 2025 |
| Geode Capital | 1,943,777 | 2.32% | Form 13F, quarter ended March 31, 2025 |
| State Street | 1,845,968 | 2.21% | Form 13F, quarter ended March 31, 2025 |
| Dimensional Fund Advisors | 1,608,477 | 1.92% | Form 13F, quarter ended March 31, 2025 |
| Two Sigma | 1,249,775 | 1.49% | Form 13F, quarter ended March 31, 2025 |
| Renaissance Technologies | 1,032,965 | 1.23% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 83,709,536 shares outstanding, as reported by EDITAS MEDICINE INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At EDITAS MEDICINE INC.'s shareholder meeting held May 29, 2025, in the 2024-2025 proxy season, 232 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 1,417 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. EDITAS MEDICINE INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, on an advisory basis, the frequency of future advisory votes on the compensation… — the reporting funds and managers cast 90% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from EDITAS MEDICINE INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
EDITAS MEDICINE INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “EDITAS MEDICINE (EDIT) 2025 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/editas-medicine-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.